These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18599274)

  • 1. The role of sirtuin proteins in obesity.
    Metoyer CF; Pruitt K
    Pathophysiology; 2008 Aug; 15(2):103-8. PubMed ID: 18599274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance.
    Arab Sadeghabadi Z; Nourbakhsh M; Pasalar P; Emamgholipour S; Golestani A; Larijani B; Razzaghy-Azar M
    Obes Res Clin Pract; 2018; 12(2):167-173. PubMed ID: 29150224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 and insulin resistance.
    Cao Y; Jiang X; Ma H; Wang Y; Xue P; Liu Y
    J Diabetes Complications; 2016; 30(1):178-83. PubMed ID: 26422395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sir2 Acts through Hepatocyte Nuclear Factor 4 to maintain insulin Signaling and Metabolic Homeostasis in Drosophila.
    Palu RA; Thummel CS
    PLoS Genet; 2016 Apr; 12(4):e1005978. PubMed ID: 27058248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1 attenuates high glucose-induced insulin resistance via reducing mitochondrial dysfunction in skeletal muscle cells.
    Zhang HH; Ma XJ; Wu LN; Zhao YY; Zhang PY; Zhang YH; Shao MW; Liu F; Li F; Qin GJ
    Exp Biol Med (Maywood); 2015 May; 240(5):557-65. PubMed ID: 25710929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on SIRtuins in Diabetes.
    Aditya R; Kiran AR; Varma DS; Vemuri R; Gundamaraju R
    Curr Pharm Des; 2017; 23(16):2299-2307. PubMed ID: 28128062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 overexpression attenuates offspring metabolic and liver disorders as a result of maternal high-fat feeding.
    Nguyen LT; Chen H; Zaky A; Pollock C; Saad S
    J Physiol; 2019 Jan; 597(2):467-480. PubMed ID: 30381838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity.
    Moschen AR; Wieser V; Gerner RR; Bichler A; Enrich B; Moser P; Ebenbichler CF; Kaser S; Tilg H
    J Hepatol; 2013 Dec; 59(6):1315-22. PubMed ID: 23928404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function.
    Kitada M; Ogura Y; Monno I; Koya D
    Front Endocrinol (Lausanne); 2019; 10():187. PubMed ID: 30972029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between SIRT1 and endocrine factors: effects on energy homeostasis.
    Quiñones M; Al-Massadi O; Fernø J; Nogueiras R
    Mol Cell Endocrinol; 2014 Nov; 397(1-2):42-50. PubMed ID: 25109279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B.
    Sun C; Zhang F; Ge X; Yan T; Chen X; Shi X; Zhai Q
    Cell Metab; 2007 Oct; 6(4):307-19. PubMed ID: 17908559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuins and Insulin Resistance.
    Zhou S; Tang X; Chen HZ
    Front Endocrinol (Lausanne); 2018; 9():748. PubMed ID: 30574122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuins in gamete biology and reproductive physiology: emerging roles and therapeutic potential in female and male infertility.
    Tatone C; Di Emidio G; Barbonetti A; Carta G; Luciano AM; Falone S; Amicarelli F
    Hum Reprod Update; 2018 May; 24(3):267-289. PubMed ID: 29447380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between low SIRT1 expression in visceral and subcutaneous adipose tissues and metabolic abnormalities in women with obesity and type 2 diabetes.
    Song YS; Lee SK; Jang YJ; Park HS; Kim JH; Lee YJ; Heo YS
    Diabetes Res Clin Pract; 2013 Sep; 101(3):341-8. PubMed ID: 23876548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes.
    Savchenko LG; Digtiar NI; Selikhova LG; Kaidasheva EI; Shlykova OA; Vesnina LE; Kaidashev IP
    Rom J Intern Med; 2019 Sep; 57(3):233-240. PubMed ID: 30901315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diet-induced obesity and insulin resistance are associated with brown fat degeneration in SIRT1-deficient mice.
    Xu F; Zheng X; Lin B; Liang H; Cai M; Cao H; Ye J; Weng J
    Obesity (Silver Spring); 2016 Mar; 24(3):634-42. PubMed ID: 26916242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 Activation by Natural Phytochemicals: An Overview.
    Iside C; Scafuro M; Nebbioso A; Altucci L
    Front Pharmacol; 2020; 11():1225. PubMed ID: 32848804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuins as possible drug targets in type 2 diabetes.
    Kitada M; Kume S; Kanasaki K; Takeda-Watanabe A; Koya D
    Curr Drug Targets; 2013 Jun; 14(6):622-36. PubMed ID: 23445543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin activators.
    Alcaín FJ; Villalba JM
    Expert Opin Ther Pat; 2009 Apr; 19(4):403-14. PubMed ID: 19441923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.